Vivitrol is the injectable version of Naltrexone, a tool used in the treatment of alcohol and opioid use disorders. It is intended for use with people who are able to abstain from drinking or using opioids in an outpatient or intensive outpatient setting. It is also indicated for use in combination with psychosocial support, such as individual counseling or group therapy.
- Vivitrol is a long-acting formulation of a currently approved drug, Naltrexone
- Vivitrol is designed for once-monthly dosing of Naltrexone and is designed to provide an additional treatment option for patients with alcohol and opioid dependence
- Naltrexone is a non-addictive, non-aversive agent that binds to opioid receptors in the brain. In people with alcohol dependence, is believed that this blockage diminishes craving for alcohol and leads to a greater ability to resist urges to excessively drink.
- Vivitrol is approved by the Food and Drug Administration (FDA) and may be a useful part of the treatment plan for some individuals with alcohol or opioid use disorder.
